Skip to main content
SpringerLink
Log in
Book cover

Renal Anemia

Conflicts and Controversies

  • Book
  • © 2002

Overview

Editors:
  1. Onyekachi Ifudu

    1. Inpatient Dialysis Services, SUNY Downstate Medical Center, Brooklyn, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • 1635 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Correcting anemia slows renal disease progression

    • Eli A. Friedman
    Pages 1-7

  3. Does treatment with EPO improve RBC survival?

    • Clinton D. Brown, Zhong H. Zhao, Lorraine L. Thomas, Robert deGroof, Eli A. Friedman
    Pages 9-13

  4. Has the best route of administration for epoetin been established?

    • Anatole Besarab, Rebecca Schmidt
    Pages 15-28

  5. Is renal anemia management determined by science or reimbursement regulations?

    • Chaim Charytan
    Pages 29-35

  6. When does anemia impact the heart in chronic kidney disease?

    • Adeera Levin
    Pages 37-47

  7. Improvements in anemia management with darbepoetin alfa, a new erythropoiesis stimulating protein

    • Jill S. Lindberg
    Pages 49-64

  8. Normalizing hematocrit in renal failure: dangerous or desirable?

    • Iain C. Macdougall
    Pages 65-80

  9. Do race, gender or mode of dialysis modulate erythropoietin response?

    • Barbara G. Delano
    Pages 81-88

  10. Are uremic inhibitors of erythropoiesis clinically relevant?

    • Onyekachi Ifudu
    Pages 89-98

  11. Do ACE inhibitors limit response to EPO and should EPO be continued in patients with sepsis or fever?

    • Moro O. Salifu
    Pages 99-106

  12. Is secondary hyperparathyroidism a significant cause of renal anemia?

    • Onyekachi Ifudu
    Pages 107-113

  13. Is long-term intravenous iron therapy risky?

    • Wendy L. St. Peter
    Pages 115-121

  14. Anemia and erythropoietin therapy in kidney transplant recipients: where are the data?

    • Onyekachi Ifudu
    Pages 123-128

  15. Intravenous iron treatment: a comparison of available drugs

    • Steven Fishbane
    Pages 129-138

  16. Epilogue

    • Eli A. Friedman
    Pages 139-140

  17. Back Matter

    Pages 141-145
    Download chapter PDF
Back to top

Keywords

About this book

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Editors and Affiliations

  • Inpatient Dialysis Services, SUNY Downstate Medical Center, Brooklyn, USA

    Onyekachi Ifudu

Bibliographic Information

  • Book Title: Renal Anemia

  • Book Subtitle: Conflicts and Controversies

  • Editors: Onyekachi Ifudu

  • DOI: https://doi.org/10.1007/978-94-015-9998-6

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2002

  • Hardcover ISBN: 978-1-4020-0678-4Published: 31 July 2002

  • Softcover ISBN: 978-90-481-6045-7Published: 07 December 2010

  • eBook ISBN: 978-94-015-9998-6Published: 29 June 2013

  • Edition Number: 1

  • Number of Pages: XI, 145

  • Topics: Nephrology, Hematology, Internal Medicine, Transplant Surgery, Diabetes

Publish with us

Policies and ethics

Back to top

Search

Navigation